STAT: Q&A: Why the World Health Organization plans a fair pricing model for drugs
“Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals. … The trick is to find the right balance between access to affordable medicines and enticing companies to develop new and improved medicines, while also ensuring lower-cost generics remain available. We spoke with Suzanne Hill, the WHO director of essential medicines and health products, about how the agency hopes to get this done…” (Silverman, 7/7).